| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2015 | TMO Thermo Fisher Scientific Inc. | Thomson Andrew J | Senior Vice President | Sell | 12,425 | $133.50 | $1,658,737.50 | -17.0% | |
| Apr 13, 2015 | TMO Thermo Fisher Scientific Inc. | Malus Alan J | Executive Vice President | Sell | 11,032 | $133.67 | $1,474,606.80 | -8.7% | |
| Apr 1, 2015 | IQV Iqvia Holdings Inc. | Gordon Kevin K51 | Exec VP And CFO | Sell | 25,000 | $66.67 | $1,666,750.00 | -58.3% | |
| Apr 1, 2015 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chief Executive Officer | Sell | 20,000 | $131.89 | $2,637,888.04 | -1.2% | |
| Mar 30, 2015 | TMO Thermo Fisher Scientific Inc. | Lynch Thomas J | Director | Sell | 5,000 | $134.40 | $672,000.00 | -33.4% | |
| Mar 30, 2015 | TMO Thermo Fisher Scientific Inc. | Loewald Thomas W | Senior Vice President | Sell | 5,307 | $134.40 | $713,260.80 | -11.5% | |
| Mar 27, 2015 | RVTY Revvity, Inc. | Goldberg Joel S58 | Please See Remarks | Sell | 10,646 | $51.00 | $542,946.00 | -16.8% | |
| Mar 25, 2015 | IQV Iqvia Holdings Inc. | Evanisko Michael J | Director | Sell | 2,500 | $67.10 | $167,750.00 | -39.7% | |
| Mar 23, 2015 | RVTY Revvity, Inc. | Okun Andrew76 | Please See Remarks | Sell | 2,000 | $50.09 | $100,180.00 | -13.1% | |
| Mar 20, 2015 | RVTY Revvity, Inc. | Corbett James | Please See Remarks | Sell | 5,157 | $50.23 | $259,025.80 | -17.3% | |
| Mar 20, 2015 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 11,390 | $7.60 | $86,564.00 | -1.6% | |
| Mar 19, 2015 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 35,000 | $7.79 | $272,750.00 | -2.3% | |
| Mar 18, 2015 | RVTY Revvity, Inc. | Goldberg Joel S58 | See Remarks | Sell | 9,000 | $49.00 | $441,000.00 | -14.6% | |
| Mar 12, 2015 | BIO Bio-Rad Laboratories, Inc. | Tsingos Christine A | EVP And CFO | Sell | 5,400 | $135.94 | $734,076.00 | -57.7% | |
| Mar 11, 2015 | BIO Bio-Rad Laboratories, Inc. | Schwartz Alice N | Director, 10% Owner | Sell | 60,000 | $134.03 | $8,041,910.40 | -1.6% | |
| Mar 10, 2015 | TMO Thermo Fisher Scientific Inc. | Sperling Scott M | Director | Sell | 11,725 | $126.75 | $1,486,143.75 | -15.3% | |
| Mar 10, 2015 | BIO Bio-Rad Laboratories, Inc. | Crowley Michael60 | EVP, Gbl Commercial Operations | Sell | 200 | $134.05 | $26,810.00 | -8.7% | |
| Mar 9, 2015 | TMO Thermo Fisher Scientific Inc. | Malus Alan J | Executive Vice President | Sell | 14,479 | $128.11 | $1,854,904.69 | -18.0% | |
| Mar 6, 2015 | RVTY Revvity, Inc. | Sullivan Patrick J | Director | Sell | 12,586 | $46.90 | $590,245.64 | -31.6% | |
| Mar 5, 2015 | TMO Thermo Fisher Scientific Inc. | Pesicka Edward A77 | Senior Vice President | Sell | 7,250 | $131.06 | $950,184.00 | -4.1% | |
| Mar 5, 2015 | RVTY Revvity, Inc. | Goldberg Joel S58 | Please See Remarks | Sell | 9,000 | $47.00 | $423,000.00 | -14.6% | |
| Mar 5, 2015 | BIO Bio-Rad Laboratories, Inc. | Soderberg Shawn Marie55 | EVP, General Counsel, Sec | Sell | 107 | $134.07 | $14,285.64 | -44.3% | |
| Mar 5, 2015 | RVTY Revvity, Inc. | Michas Alexis P68 | Director | Sell | 8,892 | $47.00 | $417,924.00 | -9.9% | |
| Mar 4, 2015 | CRL Charles River Laboratories International, Inc. | Crowley John J | SVP, Chief Accounting Officer | Sell | 912 | $76.53 | $69,792.47 | -3.9% | |
| Mar 3, 2015 | TMO Thermo Fisher Scientific Inc. | Malus Alan J | Executive Vice President | Sell | 7,870 | $130.38 | $1,026,090.60 | -8.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.